NOVO HOLDINGS A/S sold 1.1% of their position (38.60K shares) of CYTEIR THERAPEUTICS, INC. on the open market
Open‑market sale worth $106.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 7/18/2023ACC: 0001209191-23-042670
10% Owner
Since Jun 2021
-38.60K
Net shares
Net seller
$106.0K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
38.60K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−11K
Price / share
$2.74
Trade value
$30.10K
% of position
0.3%
7/14/2023
3.66M→3.65M
Common Stock
Direct
Shares
−21.10K
Price / share
$2.75
Trade value
$58K
% of position
0.6%
7/17/2023
3.65M→3.63M
Common Stock
Direct
Shares
−6.50K
Price / share
$2.76
Trade value
$17.92K
% of position
0.2%
7/18/2023
3.63M→3.62M
Total
Net shares
−38.60K
Net value
-$106.02K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/14/2023 | S · Sale | −11K | $2.74 | $30.10K | 0.3% | 3.66M | 3.65M |
| Common Stock Direct | 7/17/2023 | S · Sale | −21.10K | $2.75 | $58K | 0.6% | 3.65M | 3.63M |
| Common Stock Direct | 7/18/2023 | S · Sale | −6.50K | $2.76 | $17.92K | 0.2% | 3.63M | 3.62M |
| Total | −38.60K | -$106.02K | ||||||
Derivative Transactions0
No derivative transactions reported